Tema Heart & Health ETF (NASDAQ:HRTS) Sees Large Growth in Short Interest

Tema Heart & Health ETF (NASDAQ:HRTS) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 5,095 shares, an increase of 797.0% from the July 15th total of 568 shares. Based on an average daily volume of 9,385 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.3% of the shares of the stock are sold short.

Tema Heart & Health ETF Trading Down 0.4%

NASDAQ HRTS traded down $0.14 on Wednesday, reaching $37.57. 367 shares of the company were exchanged, compared to its average volume of 6,204. The business’s fifty day moving average price is $35.87 and its 200 day moving average price is $34.94. The stock has a market capitalization of $55.98 million, a P/E ratio of 22.06 and a beta of 0.63. Tema Heart & Health ETF has a fifty-two week low of $28.11 and a fifty-two week high of $37.79.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of HRTS. Royal Bank of Canada grew its holdings in shares of Tema Heart & Health ETF by 8.8% in the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock valued at $710,000 after purchasing an additional 1,703 shares during the period. Kestra Advisory Services LLC purchased a new position in Tema Heart & Health ETF during the fourth quarter worth about $27,000. Stifel Financial Corp raised its stake in Tema Heart & Health ETF by 19.8% during the fourth quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock worth $1,187,000 after purchasing an additional 5,571 shares during the period. Citadel Advisors LLC acquired a new position in Tema Heart & Health ETF in the 3rd quarter valued at about $243,000. Finally, Jane Street Group LLC grew its stake in shares of Tema Heart & Health ETF by 9.4% in the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after buying an additional 3,202 shares during the period.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.